Replies to post #16841 on PharmaCyte Biotech Inc (PMCB)

[jimmyjones]

Here is proof which has extended to all provinces in canada... Do you think I would be posting the problem we have in canada if we could sell I have owned shares since efsf days and followed this stock closely and have lots of shares and could make big money if I could sell.. With no one returning calls from nvlx I have to get message out and maybe they will look after canadian problem.. This is what Bcsc returned to mePolicy Documents
Decisions & Orders

Document Sub-category: Cease Trade Orders (Failure To File)
Document No.: 2011/05/27
Subject: Nuvilex, Inc. [Cease Trade Order]
Amendments:
Published Date: 05/27/2011
Effective Date: 05/27/2011


______________________________


Click on the Adobe icon to launch the Acrobat Reader



2011 BCSECCOM 250



Cease Trade Order

Nuvilex, Inc.

Section 164 of the Securities Act, R.S.B.C. 1996, c. 418


¶ 1 Nuvilex, Inc. (Nuvilex) is a Nevada corporation that is an OTC reporting issuer under BC Instrument 51-509 Issuers Quoted on the U.S. Over-the-Counter Markets (BCI 51-509).

¶ 2 Nuvilex has not filed:
1. copies of its news releases dated April 20, 2011, May 3, 2011, May 11, 2011, May 19, 2011, and May 26, 2011, and related material change reports, as required under Part 7 of NI 51-502 and section 5(b) of BCI 51-509,
2. copies of the following documents that Nuvilex filed with the United States Securities and Exchange Commission:
(a) Form 8-K Current Report dated November 11, 2010, filed April 26, 2011,

(b) Form 10-K/A Annual Report for the fiscal year ended April 30, 2010, filed April 26, 2011,

(c) Form 10-Q/A Quarterly Report for the quarterly period ended July 31, 2010, filed April 26, 2011, and

(d) Form 10-Q Quarterly Report for the quarterly period ended October 31, 2010, filed April 26, 2011,

as required under section 11.1 of NI 51-502 and section and section 5(b) of BCI 51-509, and

3. Form 51-509F2 Notice of Investor Relations Activities disclosing its agreements with Marketsmart Communications Inc., Rob Goldman, and Marlin Molinaro, Marmel Communications,
(the required records).


¶ 3 Under section 164(1) of the Act, the Executive Director orders that trading in the securities of Nuvilex cease until:

1. Nuvilex files the required records completed in accordance with the Act and regulations, and

2. The Executive Director makes an order under section 164 of the Act revoking this order.


¶ 4 May 27, 2011





John Porges
Manager
Corporate Finance